Grown Rogue International (GRUSF) Dividends Paid - Common Growth (1y) (2011 - 2018)
Grown Rogue International (GRUSF) Dividends Paid - Common Growth (1y) (2011 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 0.40% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | -2.58% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2018 | 26.27% |
| Nov 30, 2017 | -95.82% |
| May 31, 2017 | -104.13% |
| Feb 28, 2017 | 138.57% |
| Nov 30, 2016 | 483.07% |
| May 31, 2016 | 1,739.64% |
| Feb 29, 2016 | -318.93% |
| Nov 30, 2015 | 13.64% |
| May 31, 2015 | -132.57% |
| Feb 28, 2015 | -88.70% |
| Nov 30, 2014 | -87.73% |
| May 31, 2014 | 154.96% |
| May 31, 2013 | -143.73% |
| May 31, 2012 | -25.04% |
| May 31, 2011 | 964.77% |